Skip to main content

Month: August 2025

Delårsrapport 1. Januar – 30. Juni 2025

Koncernomsætningen udgjorde 645,5 mio. kr. i 1. halvår 2025 mod 633,1 mio. kr. i samme periode sidste år. Koncernens eksterne omkostninger, personaleomkostninger samt af- og nedskrivninger udgjorde samlet 672,9 mio. kr. i 1. halvår 2025, hvilket er en stigning på 69,4 mio. kr. sammenholdt med samme periode sidste år. Udviklingen i omsætningen, omkostningerne og af- og nedskrivningerne i forhold til samme periode sidste år kan primært henføres til et let fald i tilkøbsomsætning i Lalandia som følge af lidt ændret gæstemix med bl.a. flere tyske gæster samt øgede indtægter fra TV- og præmiepenge, samarbejdspartnere og øget salg af merchandise i F.C. København. Dertil kommer øgede personaleomkostninger. Resultat af transferaktiviteter udgjorde -44,8 mio. kr. mod -21,8 mio. kr. i samme periode sidste år. Resultat før skat udgjorde -91,8 mio....

Continue reading

Danish Aerospace Company A/S issues Interim report for 2025

COMPANY ANNOUNCEMENT Odense, August 25th, 2025 Company Announcement no. 63 – 25-08-2025                                 Danish Aerospace Company A/S issues Interim report for 2025 The Board of Directors of Danish Aerospace Company A/S (DAC) have today approved the interim report for 2025. The report has not been audited. The first half of 2025 shows a much stronger result compared to the same period in 2024. Highlights – Interim Report 2025Revenue was DKK 9,8 million, while Gross Profit was DKK 7,9 million. Operating Profit (EBITDA) was DKK 0,4 million, a significant increase compared to the same period last year, when EBITDA was DKK -1,65 million. Net profit was DKK -0,6 million compared to DKK -1,9 million last year. DAC signed a contract with the European Space Agency ESA to develop and build a prototype of a new exercise...

Continue reading

Major Drilling to Release Results for its First Quarter on September 8, 2025

Management to Host Webcast/Conference Call on Tuesday, September 9, 2025 at 8:00am EDT MONCTON, New Brunswick, Aug. 25, 2025 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its first quarter results, ended July 31, 2025, on Monday, September 8, 2025 after the markets have closed. Webcast/Conference Call Details Denis Larocque, President & Chief Executive Officer, and Ian Ross, Chief Financial Officer, invite you to participate in a webcast/conference call on Tuesday, September 9, 2025 at 8:00 a.m. Eastern to discuss the Company’s first quarter results for fiscal 2026. To access the webcast, which includes a slide presentation, please go to the investors/webcasts section of the Major Drilling website at www.majordrilling.com and click on the link. Please note that this is listen-only...

Continue reading

Jade Biosciences to Participate in Upcoming Conferences

SAN FRANCISCO and VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Jade Biosciences, Inc. (“Jade”), (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced its participation in the following upcoming conferences:Cantor Global Healthcare Conference (September 3–5, 2025)Fireside Chat: Tuesday, September 3 at 3:20 p.m. ET Stifel Virtual Immunology and Inflammation Forum (September 15–16, 2025)Fireside Chat: Tuesday, September 16 at 1:00 p.m. ET 11th Annual World Medical Innovation Forum, hosted by Bank of America and Mass General Brigham (September 15–17, 2025)Panel: Immunology – Creating the Next Blockbuster in I&I, Tuesday, September 16 at 4:40 p.m. ETMembers of the Jade management team will host one-on-one investor meetings during the conferences. A...

Continue reading

PDD Holdings Announces Second Quarter 2025 Unaudited Financial Results

DUBLIN and SHANGHAI, Aug. 25, 2025 (GLOBE NEWSWIRE) — PDD Holdings Inc. (“PDD Holdings” or the “Company”) (NASDAQ: PDD), today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 HighlightsTotal revenues in the quarter were RMB103,984.8 million (US$114,515.7 million), an increase of 7% from RMB97,059.5 million in the same quarter of 2024.Operating profit in the quarter was RMB25,792.9 million (US$3,600.6 million), a decrease of 21% from RMB32,564.5 million in the same quarter of 2024. Non-GAAP2 operating profit in the quarter was RMB27,747.8 million (US$3,873.4 million), a decrease of 21% from RMB34,987.3 million in the same quarter of 2024.Net income attributable to ordinary shareholders in the quarter was RMB30,753.5 million (US$4,293.0 million), a decrease of 4% from...

Continue reading

COFECE Approves Pan American Silver’s Arrangement with MAG Silver

The Arrangement is Expected to be Completed on September 4, 2025 VANCOUVER, British Columbia, Aug. 25, 2025 (GLOBE NEWSWIRE) — Pan American Silver Corp. (NYSE: PAAS) (TSX: PAAS) (“Pan American“) and MAG Silver Corp. (NYSE American: MAG) (TSX:MAG) (“MAG“) are pleased to announce that the Mexican Federal Economic Competition Commission (“COFECE”) has approved the previously announced acquisition of all of the issued and outstanding common shares of MAG (“MAG Shares”) by Pan American (the “Arrangement”). All required regulatory, shareholder and court approvals, including the final court order, have now been received and the Arrangement is anticipated to be completed on or about September 4, 2025. Election Deadline for MAG Shareholders Registered holders of MAG Shares must...

Continue reading

Park Street A/S – Park Street Interim Report Half Year 2025

Park Street A/S – Interim Financial Report, 1st half of 2025 Copenhagen, 25 August 2025 EBVAT In the first half of 2025 is DKK 13.7 million (1st half of 2024: DKK 6.5 million). Net sales were DKK 73.7 million as compared to DKK 82.3 million in the 1st half of 2024 due to reduction in properties. The increase in EBVAT was primarily driven by decrease in operating expenses due to decrease in properties and control over expenses (DKK 3.7 million) in overhead expenses (employee benefit and other external expenses) by DKK 5.8 million and reduction in financial expenses by (DKK 6.1 million). Group’s equity as of 30 June 2025 was positive at DKK 980 million. The Board of Directors of Park Street A/S discussed and today approved the company’s Interim report 2025, which contained the following: The period in outlinePark Street’s...

Continue reading

Volatus Aerospace Announces Strategic Partnership with KI Reforestation for Large-Scale Aerial Seeding Program Using Condor XL

TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSXV: FLT, OTCQB: TAKOF, FSE: ABB.F) (“Volatus” or “the Company”) announces today the selection of its Condor XL Remotely Piloted helicopter for the next-generation aerial seeding operations by Ki Reforestation (“Ki”). The Company will operate the platform for Ki, marking a significant milestone in the automation of reforestation across Canada’s fire-impacted landscapes. Ki Reforestation is a Toronto-based environmental innovation company specializing in wildfire recovery and large-scale reforestation. In 2023 and 2024, more than 18 million hectares of Canadian forest burned, an area larger than many provinces. Natural regeneration can no longer keep pace, creating a widening gap that threatens biodiversity, water security, and climate resilience....

Continue reading

Auddia Announces Restructuring of Engineering Team in Preparation for Business Combination

Restructuring projected to reduce engineering costs by $750,000 annually Current lead AI engineer to join the AI engineering team at the holding company level upon closing of the proposed business combination Utilization of internal and dedicated outsourced engineering talent expected to significantly increase the speed of product development BOULDER, Colo., Aug. 25, 2025 (GLOBE NEWSWIRE) — Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) (“Auddia” or the “Company”), an AI first technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with audio, today announced a restructuring of its engineering team aimed at significantly reducing costs while positioning the Company for its AI native holding company structure upon closing of the previously announced business...

Continue reading

Royalty Pharma to Acquire Royalty Interest in Amgen’s Imdelltra for up to $950 Million

Imdelltra is a first-in-class immunotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) marketed by Amgen Royalty Pharma to pay $885 million upfront; BeOne Medicines to retain a $65 million option to sell additional portion of its royaltyNEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired a royalty interest in Amgen’s Imdelltra, a first-in-class DLL3 targeting bispecific T-cell engager (BiTE), from BeOne Medicines for $885 million upfront. The agreement includes an option for BeOne to sell additional Imdelltra royalties to Royalty Pharma for up to $65 million within the next 12 months. “We are excited to acquire this royalty stream from BeOne Medicines, a global oncology company advancing innovative treatments,” said Pablo Legorreta, Royalty...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.